Lyell Immunopharma, Inc. Capital Expenditures Incurred but Not yet Paid
Lyell Immunopharma, Inc. (LYEL) reported Capital Expenditures Incurred but Not yet Paid of $77.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$115.00K.
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $192.00K, a 23.87% increase year-over-year.
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$9.00K.
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $144.00K, a 396.55% increase from fiscal 2023.
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $29.00K, a 97.81% decline from fiscal 2022.
- Lyell Immunopharma, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $1.32M, a 71.23% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $77.00K 10-Q · filed 2026-08-06 | $77.00K derived: sum of 3 quarters · filed 2026-08-06 | $68.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $192.00K 10-Q · filed 2026-05-06 | $192.00K derived: sum of 2 quarters · filed 2026-05-06 | $183.00K derived: sum of 3 quarters · filed 2026-05-06 | $37.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$9.00K derived: sum of 2 quarters · filed 2026-03-12 | -$155.00K derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$155.00K derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-12 | $121.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.00K 10-Q · filed 2026-08-06 | $130.00K derived: sum of 3 quarters · filed 2026-08-06 | $103.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $155.00K 10-Q · filed 2026-05-06 | $276.00K derived: sum of 2 quarters · filed 2026-05-06 | $249.00K derived: sum of 3 quarters · filed 2026-05-06 | $79.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $94.00K derived: sum of 2 quarters · filed 2026-03-12 | -$76.00K derived: sum of 3 quarters · filed 2026-03-12 | $144.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$197.00K derived: sum of 2 quarters · filed 2025-11-12 | $23.00K 10-Q · filed 2025-11-12 | $50.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $50.00K 10-Q · filed 2025-08-12 | $77.00K derived: sum of 3 quarters · filed 2026-03-12 | $46.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $220.00K 10-Q · filed 2025-05-13 | $247.00K derived: sum of 2 quarters · filed 2026-03-12 | $216.00K derived: sum of 3 quarters · filed 2026-03-12 | -$146.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$4.00K derived: sum of 2 quarters · filed 2026-03-12 | -$366.00K derived: sum of 3 quarters · filed 2026-03-12 | $29.00K 10-K · filed 2026-03-12 |
| 2023-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$393.00K derived: sum of 2 quarters · filed 2024-11-07 | $2.00K 10-Q · filed 2024-11-07 | -$2.24M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | -$362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $33.00K 10-Q · filed 2024-08-07 | -$2.21M derived: sum of 3 quarters · filed 2025-03-11 | -$2.19M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $395.00K 10-Q · filed 2024-05-06 | -$1.84M derived: sum of 2 quarters · filed 2025-03-11 | -$1.83M derived: sum of 3 quarters · filed 2025-03-11 | $1.61M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$2.23M derived: sum of 2 quarters · filed 2025-03-11 | $1.22M derived: sum of 3 quarters · filed 2025-03-11 | $1.32M 10-K · filed 2025-03-11 |
| 2022-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.46M derived: sum of 2 quarters · filed 2023-11-07 | $3.56M 10-Q · filed 2023-11-07 | $2.74M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.55M 10-Q · filed 2023-08-08 | $2.73M derived: sum of 3 quarters · filed 2024-02-28 | $1.58M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $107.00K 10-Q · filed 2023-05-04 | -$720.00K derived: sum of 2 quarters · filed 2024-02-28 | -$1.87M derived: sum of 3 quarters · filed 2024-02-28 | -$8.83M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$827.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$1.97M derived: sum of 2 quarters · filed 2024-02-28 | -$8.94M derived: sum of 3 quarters · filed 2024-02-28 | $4.61M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$8.11M derived: sum of 2 quarters · filed 2022-11-08 | $5.43M 10-Q · filed 2022-11-08 | -$267.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$6.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $6.58M 10-Q · filed 2022-08-04 | $880.00K derived: sum of 3 quarters · filed 2023-02-28 | $12.88M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $13.54M 10-Q · filed 2022-05-10 | $7.84M derived: sum of 2 quarters · filed 2023-02-28 | $19.84M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.30M derived: sum of 2 quarters · filed 2023-02-28 | $12.74M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $18.44M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $6.44M 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $3.19M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |